维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

17篇 您的检索式：作者名="STEEGHS N"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Simple and safe exclusion of pulmonary embolism in outpatients using quantitative D-dimer and Wells' simplified decision rule显示文摘	Goekoop R J Steeghs N Niessen R W		0，，01：	1
	2	C - reactive protein and D - dimer with clinical probability score in the exclu- sion of pulmonary embolism显示文摘	STEEGHS N GOEKOOP R J NIESSEN R W	2005	Br J Haematol2005，30，4：	1
	3	Phase I dose escalation study of telatinib,a tyrosine kinase inhibitor of vascular endothelial growth factor receptor 2and 3,platelet-derived growth factor receptorβ,and cKit,in patients with advanced or metastatic solid tumors显示文摘	ESKENS F STEEGHS N VERWEIJ J	2009	J Clin Oncol2009，27，25：	1
	4	C-reactive protein and D-dimer with clinical probability score in the exclusion of pulmonary embolism显示文摘	Steeghs N Goekoop RJ Niessen RW	2005	Br J Haematol2005，130，4：	1
	5	Small molecule tyrosinek- inase inhibitors in the treatment of solid tumors:an update on re- cent developments显示文摘	Steeghs N Nortier JW Gelderblom H	2007	Ann Surg Oneol2007，14，2：	1
	6	C - reactive protein and D - dimer with clinical probability score in the exclusion of pulmonary em- bolis 显示文摘	Steeghs N Goekoop J Niessen RW	2005	BrJ Haematol2005，130，4：	1
	7	Phase I dose escalation study of telatinib, a tyrosine kinase inhibitor of vascular endothelial growth factor receptor 2 and 3, platelet- derived growth factor beta, and c-Kit, in patients with advanced or metastatic solid tumors显示文摘	ESKENS FA STEEGHS N VERWEIJ J	2009	J Clin Oncol2009，27，25：	1
	8	Simple and safe exclusion of pulmonary embolism in outpatients using quantitative D-dimer and Wells' simplified decision rule显示文摘	Goekoop RJ Steeghs N Niessen RW	2007	Thromb Haemost2007，97，1：	1
	9	VEGFR2 blockade in patients with solid tumors:Mechanism of hypertension and effects on vascular function显示文摘	STEEGHS N HOVENS M M RABELINK A J	2006	J Clin Oncol2006，，13：	1
	10	Small molecule tyrosine kinase inhibitors in the treatment of solid tumors:an update of recent developments显示文摘	Nortier JW Gelderblom H	2007	Ann Surg Oncol2007，14，2：	1
	11	C-reactive protein and Ddimer with clinical probability score in the exclusion of pulmonary embolism显示文摘	Steeghs N Goekoop RJ Niessen RW	2005	Br J Haematol2005，130，4：	1
	12	Hypertension and rarefaction during treatment with telatinib, a small molecule angiogenesis inhibitor显示文摘	Steeghs N Gelderblom H Roodt J O	2008	Clin Cancer Res2008，14，：	1
	13	C-reactive protein and Ddimer with clinical probability score in the exclusion of pulmonary embolism显示文摘	Steeghs N Goekoop R J Niessen RW	2005	Br J haematol2005，130，4：	1
	14	Decreased exposure to sunitinib due to concomitant administration of ifosfamide: results of a phase I and pharmacokinetic study on the combination of sunitinib and ifosfamide in patients with advanced solid malignancies 显示文摘	Hamberg P Steeghs N Loos W J	2010	Br J Cancer2010，102，12：	1
	15	Decreased expo- sure to sunitinib due to concomitant administration of ifos- famide: results of a phase I and pharmacokinetic study on the combination of sunitinib and ifosfamide in patients with advanced solid malignancies显示文摘	Hamberg P Steeghs N Loos WJ	2010	Br J Cancer2010，102，12：	1
	16	c Amp/PKA Signaling inhibits osteogenic differentiation and bone formation in rodent models显示文摘	Siddappa R mudder N Steegh I	2009	Tissue Eng Part A2009，15，8：	1
	17	Simple and safe exclu-sion ofpulmonary embolism in outpatients using quantitative D-dimerandWells' simplified decision rule显示文摘	Goekoop RJ Steeghs N Niessen RW		0，，01：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费